Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-19-039324

Options or other derivatives

  • Director acquired 240,541 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Furey John Director 2019-07-02 Grant or award · Option to purchase Ordinary Shares +240,541 240,541 D
Loading xslF345X03/a4.xml…